Varie
Suvoda Announces Participation at CTS Europe Conference in Madrid, March 22-23
In its first industry event since announcing a corporate rebranding earlier this month, Suvoda will be sharing clinical trial supply strategy insights and best practices in two key presentations on March 22 , including:
How to Optimize your Trial Supply Chain with a Flexible IRT
Overview: Attendees will gain insight into the value of IRT for improved supply chain efficiency
Speakers:
Panel Discussion - Navigating the Journey to Decentralized Trials: Establishing a Successful Patient-Centric Clinical Trial Supply Chain Resulting in Enhanced Patient Retention
Moderator: Jennifer Smith-Parker , Senior Editor, GD Healthcare
Speakers:
Building on Suvoda's momentum in 2021, the Company recently refreshed its brand and expanded beyond its flagship IRT product with the release of its eConsent and eCOA solutions, now in the early adopter phase, marking a critical step in the company's path to streamline complex clinical trials.
Suvoda will be highlighting these developments and how companies can at the CTS Europe conference this month. For more details, you can register for CTS Europe here and experience the new Suvoda at www.suvoda.com .
Suvoda is a global clinical trial technology company that specializes in highly complex, life-sustaining studies in therapeutic areas like oncology, central nervous system, and rare disease. Founded in 2013 by experts in eClinical technologies, Suvoda empowers clinical trial professionals to manage the most urgent moments in the most urgent trials through its IRT, eConsent, and eCOA solutions delivered on a single platform. Headquartered outside Philadelphia , Suvoda also maintains offices in Portland, OR , Barcelona, Spain , Bucharest, Romania and Tokyo, Japan . The company consistently boasts a customer satisfaction index of 9 out of 10, an NPS score of 70 in its annual surveys, and has been selected by trial sponsors and CROs to support nearly 1000 trials across 65 countries. To learn more, visit suvoda.com. Follow Suvoda on Twitter and LinkedIn.
Logo - https://mma.prnewswire.com/media/1759317/Suvoda_Logo.jpg